BMK-202
Solid Tumors (Immuno‑oncology)
PreclinicalActive
Key Facts
About Biomakers
Argentinian biotech Biomakers develops engineered biologics for oncology and immunology using a proprietary protein‑engineering platform.
View full company profileSolid Tumors (Immuno‑oncology)
Argentinian biotech Biomakers develops engineered biologics for oncology and immunology using a proprietary protein‑engineering platform.
View full company profile